Affiliation:
1. «Peoples’ Friendship University of Russia» (RUDN University)
2. «Peoples’ Friendship University of Russia» (RUDN University); «I.M. Sechenov First Moscow State Medical University» (Sechenov University)
3. «Stavropol State Medical University»
4. «Lomonosov Moscow State University»
Abstract
Relevance. Simvastatin is a statin drug used for the clinical control of hypercholesterolemia. Over the past decades, there has been a steady increase in the number of studies on the possibilities of simvastatin, in many respects superior to the effect of lowering blood cholesterol levels. The use of simvastatin in the field of bone tissue regeneration, as well as its ability to reduce the inflammatory response, is being actively investigated.The purpose of the review: to consider modern ideas about simvastatin and to study its pleiotropic effects.Materials and methods. The analysis of scientific publications in the electronic databases eLIBRARY, PubMed and Google Scholar (articles, meta-analyses, systematic reviews) for the time interval from 2015 to 2022 was carried out. Materials containing information on the hypocholes-terolemic activity of simvastatin and its mechanism of action, the use of simvastatin in periodontal practice, as well as the osteoinductive effect of simvastatin and its use in bone engineering are included.Results. The review reviewed 83 articles, from which 53 articles were selected after reviewing the literature.Conclusion. Based on the analyzed data, it can be concluded that the effects of simvastatin are multifaceted. Its anti-inflammatory activity has been proven by inhibiting interleukins and inflammatory mediators, participation in bone tissue regeneration by gene expression and stimulation of osteoblast cell differentiation.
Subject
Materials Chemistry,Economics and Econometrics,Media Technology,Forestry
Reference53 articles.
1. Yao X., Xie R., Cao Y., Tang J., Men Y., Peng H., Yang W. Simvastatin induced ferroptosis for triple-negative breast cancer therapy. J Nanobiotechnology. 2021; 19(1):311. doi: 10.1186/s12951-021-01058-1.
2. Strandberg T.E. Role of Statin Therapy in Primary Prevention of Cardiovascular Disease in Elderly Patients. Curr Atheroscler Rep. 2019; 21(8):28. doi: 10.1007/s11883-019-0793-7.
3. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012. Simvastatin. 2021. PMID: 31644029.
4. Talreja O., Kerndt C.C., Cassagnol M. Simvastatin. 2022. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. PMID: 30422514.
5. Danilov A.I., Kozlov S.N., Evseev A.V. Statins as a component of lipid-lowering therapy. Reviews on Clinical Pharmacology and Drug Therapy. 2019; (4):79–82. doi: 10.17816/RCF17479-82.